JP2016506398A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016506398A5 JP2016506398A5 JP2015548006A JP2015548006A JP2016506398A5 JP 2016506398 A5 JP2016506398 A5 JP 2016506398A5 JP 2015548006 A JP2015548006 A JP 2015548006A JP 2015548006 A JP2015548006 A JP 2015548006A JP 2016506398 A5 JP2016506398 A5 JP 2016506398A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- use according
- antipruritic
- administered
- pruritus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261737488P | 2012-12-14 | 2012-12-14 | |
| US13/715,625 US8637538B1 (en) | 2012-12-14 | 2012-12-14 | Methods for treatment of pruritis |
| US13/715,625 | 2012-12-14 | ||
| US61/737,488 | 2012-12-14 | ||
| PCT/US2013/075096 WO2014093871A1 (en) | 2012-12-14 | 2013-12-13 | Methods for treating pruritus |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071738A Division JP6823857B2 (ja) | 2012-12-14 | 2019-04-04 | 抗そう痒剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016506398A JP2016506398A (ja) | 2016-03-03 |
| JP2016506398A5 true JP2016506398A5 (enExample) | 2017-01-26 |
Family
ID=50935003
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015548006A Pending JP2016506398A (ja) | 2012-12-14 | 2013-12-13 | そう痒の処置法 |
| JP2019071738A Active JP6823857B2 (ja) | 2012-12-14 | 2019-04-04 | 抗そう痒剤 |
| JP2020179395A Active JP7072280B2 (ja) | 2012-12-14 | 2020-10-27 | 抗そう痒剤 |
| JP2022072885A Pending JP2022105095A (ja) | 2012-12-14 | 2022-04-27 | 抗そう痒剤 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019071738A Active JP6823857B2 (ja) | 2012-12-14 | 2019-04-04 | 抗そう痒剤 |
| JP2020179395A Active JP7072280B2 (ja) | 2012-12-14 | 2020-10-27 | 抗そう痒剤 |
| JP2022072885A Pending JP2022105095A (ja) | 2012-12-14 | 2022-04-27 | 抗そう痒剤 |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP2931279B1 (enExample) |
| JP (4) | JP2016506398A (enExample) |
| KR (3) | KR20210050585A (enExample) |
| CN (2) | CN110585209A (enExample) |
| AU (2) | AU2013359017B2 (enExample) |
| BR (1) | BR112015013984A2 (enExample) |
| CA (1) | CA2892393C (enExample) |
| ES (1) | ES2984559T3 (enExample) |
| MX (1) | MX2015007518A (enExample) |
| NZ (1) | NZ708371A (enExample) |
| RU (1) | RU2015128265A (enExample) |
| WO (1) | WO2014093871A1 (enExample) |
| ZA (2) | ZA201504229B (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| US20140179727A1 (en) | 2012-12-14 | 2014-06-26 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| ES2984559T3 (es) * | 2012-12-14 | 2024-10-29 | Trevi Therapeutics Inc | Métodos de tratamiento del prurito |
| US20150359789A1 (en) * | 2014-06-13 | 2015-12-17 | Trevi Therapeutics, Inc. | Methods for treating pruritus |
| HRP20251395T1 (hr) | 2015-06-04 | 2026-02-13 | Sol-Gel Technologies Ltd. | Topikalne formulacije za isporuku spojeva inhibitora hedgehog signalnog puta i njihova uporaba |
| TW201725041A (zh) * | 2016-01-04 | 2017-07-16 | 懷特生技新藥股份有限公司 | 治療皮膚癢之醫藥組合物 |
| CN105560202B (zh) * | 2016-03-11 | 2019-05-24 | 广州玻思韬控释药业有限公司 | 一种盐酸纳布啡凝胶骨架缓释片的制备方法及应用 |
| KR20180120756A (ko) * | 2016-03-21 | 2018-11-06 | 트레비 테라퓨틱스, 인코포레이티드 | 요독증성 소양증의 치료 |
| US20180125840A1 (en) * | 2016-10-25 | 2018-05-10 | Trevi Therapeutics, Inc. | Treatment of prurigo nodularis |
| JP7390695B2 (ja) * | 2017-02-03 | 2023-12-04 | 株式会社東洋新薬 | 錠剤及び錠剤の製造方法 |
| IL318587A (en) * | 2018-07-23 | 2025-03-01 | Trevi Therapeutics Inc | Treatment of chronic cough, shortness of breath and wheezing |
| CA3166928A1 (en) | 2020-01-10 | 2021-07-15 | Trevi Therapeutics, Inc. | Methods of administering nalbuphine |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE359076T1 (de) * | 1996-11-25 | 2007-05-15 | Toray Industries | Mittel gegen juckreiz |
| US20030054030A1 (en) * | 2001-09-13 | 2003-03-20 | Gary Gordon | Method and compositions for the treatment of pruritus |
| US6703398B2 (en) * | 2001-11-26 | 2004-03-09 | Oliver Yoa-Pu Hu | Orally administered analgesic compositions containing nalbuphine |
| CA2478515C (en) * | 2002-04-05 | 2010-09-28 | Purdue Pharma | Pharmaceutical preparation containing oxycodone and naloxone |
| JP2008502603A (ja) * | 2004-06-03 | 2008-01-31 | バーボーム，ジョナサン，ジェイ． | そう痒症を処置するための医薬組成物 |
| EP2402005B1 (en) | 2005-08-24 | 2020-12-16 | Endo Pharmaceuticals Inc. | Sustained release formulations of nalbuphine |
| US8394812B2 (en) * | 2005-08-24 | 2013-03-12 | Penwest Pharmaceuticals Co. | Sustained release formulations of nalbuphine |
| FR2963889B1 (fr) * | 2010-08-20 | 2013-04-12 | Debregeas Et Associes Pharma | Formulations a base de nalbuphine et leurs utilisations |
| ES2984559T3 (es) * | 2012-12-14 | 2024-10-29 | Trevi Therapeutics Inc | Métodos de tratamiento del prurito |
-
2013
- 2013-12-13 ES ES13863494T patent/ES2984559T3/es active Active
- 2013-12-13 EP EP13863494.4A patent/EP2931279B1/en active Active
- 2013-12-13 KR KR1020217012252A patent/KR20210050585A/ko not_active Ceased
- 2013-12-13 NZ NZ708371A patent/NZ708371A/en unknown
- 2013-12-13 CN CN201910603708.9A patent/CN110585209A/zh active Pending
- 2013-12-13 WO PCT/US2013/075096 patent/WO2014093871A1/en not_active Ceased
- 2013-12-13 AU AU2013359017A patent/AU2013359017B2/en active Active
- 2013-12-13 KR KR1020227010137A patent/KR20220044385A/ko not_active Ceased
- 2013-12-13 KR KR1020157015561A patent/KR20150093702A/ko not_active Ceased
- 2013-12-13 BR BR112015013984A patent/BR112015013984A2/pt not_active Application Discontinuation
- 2013-12-13 MX MX2015007518A patent/MX2015007518A/es unknown
- 2013-12-13 JP JP2015548006A patent/JP2016506398A/ja active Pending
- 2013-12-13 RU RU2015128265A patent/RU2015128265A/ru not_active Application Discontinuation
- 2013-12-13 CA CA2892393A patent/CA2892393C/en active Active
- 2013-12-13 CN CN201380072542.3A patent/CN104981246A/zh active Pending
-
2015
- 2015-06-11 ZA ZA2015/04229A patent/ZA201504229B/en unknown
-
2018
- 2018-08-09 AU AU2018214098A patent/AU2018214098B2/en active Active
-
2019
- 2019-04-04 JP JP2019071738A patent/JP6823857B2/ja active Active
- 2019-09-26 ZA ZA2019/06339A patent/ZA201906339B/en unknown
-
2020
- 2020-10-27 JP JP2020179395A patent/JP7072280B2/ja active Active
-
2022
- 2022-04-27 JP JP2022072885A patent/JP2022105095A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017517553A5 (enExample) | ||
| RU2015128265A (ru) | Способы лечения зуда | |
| Lee et al. | The uses of naltrexone in dermatologic conditions | |
| RU2017101102A (ru) | Способы лечения зуда | |
| Prommer et al. | Management of pain in the elderly at the end of life | |
| AU2016371598B2 (en) | Method for preventing and/or treating aging-associated cognitive impairment and neuroinflammation | |
| FI3463345T3 (fi) | Farmaseuttisia yhdistelmiä | |
| Lim et al. | Treatment effectiveness and tolerability of afatinib at different doses in patients with EGFR-mutated lung adenocarcinoma: How low can we go? | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| WO2009047562A1 (en) | Methods and compositions for the treatment of pruritus | |
| JP2018521047A (ja) | 掻痒の治療 | |
| CA3224094A1 (en) | Use of tricyclic heteroaryl-containing compound | |
| US20170216277A1 (en) | Therapeutic use of nalbuphine without aquaretic effects | |
| Partownavid et al. | Sugammadex: a comprehensive review of the published human science, including renal studies | |
| Al-Hejjaj et al. | Anti-inflammatory activity of telmisartan in rat models of experimentally-induced chronic inflammation: Comparative study with dexamethasone | |
| Miyazaki et al. | Topical morphine gel for pain management in head and neck cancer patients | |
| MX2007006637A (es) | Uso de atazanavir para mejorar los parametros farmacocineticos de farmacos metabolizados por isoforma 1a1 de udp-glucuronosil- transferasa. | |
| JP2019509309A5 (enExample) | ||
| JP2019531286A5 (enExample) | ||
| MX2018005298A (es) | Regimen de dosificacion para un inhibidor de fosfatidilinositol 3-quinasa. | |
| RU2013105513A (ru) | Производные 1-аминоалкилциклогексана для лечения воспалительных заболеваний кожи | |
| WO2013026772A1 (en) | Flurbiprofen and related compounds for the treatment of skin diseases | |
| JP2023184678A (ja) | 皮膚線維症を処置するための組成物および方法 | |
| ITMI20080798A1 (it) | Composizione a rilascio modificato a base di doxofillina | |
| MX2007012052A (es) | Composiciones y sales dermatologicas para el tratamiento de enfermedades dermatologicas. |